info@p-95.com

Clinical Trial Delivery

Comprehensive Clinical Trial Support for Vaccines and Infectious Disease.

Data, Analysis and writing

Our data management, biostatistics, safety management and medical writing teams ensure data integrity and insightful analysis for vaccines and drugs across all stages of development.

Epidemiology and Real-World Evidence (RWE) Solutions

Comprehensive Epidemiology and RWE solutions for Vaccines and Infectious Diseases.

Africa and LMICs

Expanding Clinical and Epidemiological Horizons: Expertise in Africa, LMICs, and Beyond.

VIEW ALL SERVICES

CATEGORY ARCHIVE
News

metus vulputate eu scelerisque felis imperdiet proin fermentum leo vel orci porta non pulvinar neque laoreet suspendisse interdum consectetur libero id faucibus nisl tincidunt eget nullam non nisi est sit

P95 appoints Henk Hoornaert as Chief Commercial Officer

P95 appoints Henk Hoornaert as Chief Commercial Officer

P95 has appointed Henk Hoornaert as Chief Commercial Officer (CCO). After two years of accelerated growth, this appointment will strengthen P95’s structure and improve business development, marking a further step towards a more stable and mature organization.

Largest ever Lassa fever study expands to more countries in West Africa

Largest ever Lassa fever study expands to more countries in West Africa

July 28 2021, Oslo Norway, Cotonou Benin, Conakry Guinea, Monrovia Liberia, Abuja Nigeria, and Kenema Sierra Leone – The largest ever study created and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to provide a more accurate assessment of the incidence of Lassa fever infections has launched in several more countries in West Africa.